[ad_1] Deciphera Prescription drugs (NASDAQ:DCPH – Get Unfastened File) used to be upgraded through inventory analysts at Jonestrading from a “cling” ranking to a “purchase” ranking in a analysis document issued on Tuesday, Benzinga reviews. A number of different equities analysts have additionally commented on DCPH. Piper Sandler raised Deciphera Prescription drugs from a “impartial” […]